Back to blog page
July 17, 2025
Traditional lipid tests, like total cholesterol and LDL-C, provide a limited view of cardiometabolic risk. While these basic markers are widely used, they may not reveal underlying metabolic imbalances. Advanced lipid testing offers deeper insights by assessing LDL particle number (LDL-P), Apolipoprotein B (ApoB) test, triglyceride-to-HDL ratio (TG:HDL), and oxidized LDL (OxLDL). These biomarkers help identify cardiovascular and metabolic health risks early, allowing for personalized cardiometabolic risk analysis and intervention.
At The FunctionalMD Clinic, we go beyond traditional tests to provide a functional medicine lipid panel that uncovers hidden risks and enables precise, individualized care plans.
While total cholesterol is a basic marker, it is only a starting point. A deeper evaluation of cholesterol fractions and their impact on metabolic health is necessary.
LDL-C levels alone do not provide the full picture. More critical markers include LDL particle number (LDL-P) and Apolipoprotein B (ApoB) test, which indicate the actual number of atherogenic particles in circulation.
➡ Why It Matters: High small, dense LDL particles are more likely to penetrate arterial walls, increasing cardiovascular risk.
Although HDL-C is often called “good cholesterol,” recent studies show that dysfunctional HDL particles may not always protect against cardiometabolic risk.
Non-HDL cholesterol includes all atherogenic lipoproteins and is a stronger predictor of cardiovascular risk than LDL-C alone.
ApoB measures the number of atherogenic lipoproteins, including LDL, VLDL, and IDL. Since each of these carries a single ApoB molecule, this marker provides a direct measure of cardiovascular risk.
LDL-P assesses the concentration of LDL particles, while subfraction analysis categorizes them by size. Small, dense LDL particles are more atherogenic and linked to insulin resistance.
High triglycerides (TG) are associated with insulin resistance and metabolic syndrome. The triglyceride-to-HDL ratio (TG:HDL) is a powerful predictor of cardiometabolic risk.
Lp(a) is a genetically determined lipoprotein that increases cardiovascular risk independently of other lipid markers.
Oxidized LDL (OxLDL) is highly atherogenic and plays a key role in plaque formation, making it a critical marker for chronic inflammation and cardiovascular health.
Beyond individual markers, specific ratios provide deeper insight into cardiometabolic risk assessment:
At The Functional MD Clinic, we use a functional medicine approach to cholesterol and advanced lipid testing to identify risks before they escalate. Here’s what we offer:
At The Functional MD Clinic, our strategies address cardiometabolic risk by targeting root causes:
Advanced lipid testing provides the insights needed to address risks before they escalate into chronic conditions. By understanding your unique lipid profile, The Functional MD Clinic can help you take meaningful steps toward improved health.
👉 Visit FunctionalMDClinic.com to schedule your consultation today.
The information provided in this blog is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Functional Medicine is a complementary approach designed to support overall health and wellness and should not replace traditional medical care. The therapies and strategies discussed are not universally appropriate and may not align with standard care practices. Always consult with a licensed healthcare provider before making any changes to your health plan or treatment regimen. Individual results may vary.